China Influenza Vaccine Market 2018 - Industry, Analysis, Share, Growth, Sales, Trends, Supply, Forecast to 2025

Download as PDF 

 Published: Aug-2018 |  Format: PDF | QY Research |  Number of pages: 124 |

Description
This report studies the Influenza Vaccine development status and future trend in China, focuses on top players in China, also splits Influenza Vaccine by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

In the last several years, China market of Influenza Vaccine developed fluctuation, with an average growth rate of -9.03%. In 2017, China Revenue of Influenza Vaccine is nearly 75.13 M USD; the actual production is about 29.17 M Doses.

The major players in global market include 
Hualan Bio
SANOFI
CCBIO
Changsheng Biological
SINOVAC
SIOBP
Aleph Biomedical
Adimmune
ZYAK
GSK
Aimei Hissen
Tianyuan Bio-pharma
Simcere Vaxtec
Tiantan Biological


Geographically, this report splits the China market into six regions, 
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China


On the basis of product, the Influenza Vaccine market is primarily split into 
Split Influenza Vaccine
Pandemic Influenza Vaccine
Subunit Influenza Vaccine

On the basis on the end users/applications, this report covers 
For Children (6 months to 3 years)
For Adults and Children over 3 years
Table of Content

1 Influenza Vaccine Overview	1
1.1 Product Overview and Scope of Influenza Vaccine	1
1.2 Classification of Influenza Vaccine by Product Category	2
1.2.1 China Influenza Vaccine Sales Comparison by Types (2013-2025)	2
1.2.2 China Influenza Vaccine Sales Market Share by Types in 2017	2
1.2.3 Inactivated Influenza Vaccine	3
1.2.4 Pandemic Influenza Vaccine	3
1.2.5 Subunit Influenza Vaccine	4
1.3 China Influenza Vaccine Market by Applications/End Users	4
1.3.1 China Influenza Vaccine Sales and Market Share Comparison by Applications (2013-2025)	4
1.3.2 For Children (6 months to 3 years)	5
1.3.3 For Adults and Children over 3 years	6
1.4 China Influenza Vaccine Market by Regions	6
1.4.1 China Influenza Vaccine Market Size Comparison by Regions (2013-2025)	6
1.4.2 South China Influenza Vaccine Status and Prospect (2013-2025)	7
1.4.3 East China Influenza Vaccine Status and Prospect (2013-2025)	8
1.4.4 Southwest China Influenza Vaccine Status and Prospect (2013-2025)	9
1.4.5 Northeast China Influenza Vaccine Status and Prospect (2013-2025)	10
1.4.6 North China Influenza Vaccine Status and Prospect (2013-2025)	11
1.4.7 Central China Influenza Vaccine Status and Prospect (2013-2025)	12
1.4.8 Northwest China Influenza Vaccine Status and Prospect (2013-2025)	13
1.5 China Market Size (Sales and Revenue) of Influenza Vaccine (2013-2025)	14
1.5.1 China Influenza Vaccine and Growth Rate (%) (2013-2025)	14
1.5.2 China Influenza Vaccine Revenue and Growth Rate (2013-2025)	15
1.6 Macroscopic Indicator	16
1.6.1 GDP for Major Regions	16
1.6.2 Population and Labor Considered for Forecast	18
1.6.3 Disposable Income Considered for Forecast	20
2 China Influenza Vaccine Market Competition by Players/Manufacturers	22
2.1 China Influenza Vaccine Sales and Market Share of Key Players/Manufacturers (2013-2018)	22
2.2 China Influenza Vaccine Revenue and Share by Players/Manufacturers (2013-2018)	24
2.3 China Influenza Vaccine Average Price by Players/Manufacturers (2013-2018)	27
2.4 China Influenza Vaccine Market Competitive Situation and Trends	29
2.4.1 China Influenza Vaccine Market Concentration Rate	29
2.4.2 China Influenza Vaccine Market Share of Top 3 and Top 5 Players/Manufacturers	30
2.4.3 Mergers & Acquisitions, Expansion in China Market	31
2.5 China Players/Manufacturers Influenza Vaccine Headquarters and Established Date	34
3 China Influenza Vaccine Sales and Revenue by Regions (2013-2018)	35
3.1 China Influenza Vaccine Sales and Market Share by Regions (2013-2018)	35
3.2 China Influenza Vaccine Revenue and Market Share by Regions (2013-2018)	37
3.3 China Influenza Vaccine Price by Regions (2013-2018)	39
4 China Influenza Vaccine Sales and Revenue by Type/ Product Category (2013-2018)	40
4.1 China Influenza Vaccine Sales and Market Share by Type/ Product Category (2013-2018)	40
4.2 China Influenza Vaccine Revenue and Market Share by Type (2013-2018)	42
4.3 China Influenza Vaccine Price by Type (2013-2018)	44
4.4 China Influenza Vaccine Sales Growth Rate (%) by Type (2013-2018)	44
5 China Influenza Vaccine Sales by Application (2013-2018)	45
5.1 China Influenza Vaccine Sales and Market Share by Applications (2013-2018)	45
5.2 China Influenza Vaccine Sales Growth Rate (%) by Applications (2013-2018)	47
6 Analysis of Influenza Vaccine Industry Key Manufacturers	48
6.1 Hualan Bio	48
6.1.1 Company Profile	48
6.1.2 Product Information	49
6.1.3 Sales, Price, Revenue and Gross Margin	49
6.2 SANOFI	50
6.2.1 Company Profile	50
6.2.2 Product Information	51
6.2.3 Sales, Price, Revenue and Gross Margin	51
6.3 CCBIO	51
6.3.1 Company Profile	51
6.3.2 Product Information	53
6.3.3 Sales, Price, Revenue and Gross Margin	53
6.4 Changsheng Biological	54
6.4.1 Company Profile	54
6.4.2 Product Information	55
6.4.3 Sales, Price, Revenue and Gross Margin	55
6.5 SINOVAC	55
6.5.1 Company Profile	55
6.5.2 Product Information	56
6.5.3 Sales, Price, Revenue and Gross Margin	57
6.6 SIOBP	57
6.6.1 Company Profile	57
6.6.2 Product Information	59
6.6.3 Sales, Price, Revenue and Gross Margin	59
6.7 Aleph Biomedical	59
6.7.1 Company Profile	59
6.7.2 Product Information	60
6.7.3 Sales, Price, Revenue and Gross Margin	61
6.8 Adimmune	61
6.8.1 Company Profile	61
6.8.2 Product Information	62
6.8.3 Sales, Price, Revenue and Gross Margin	62
6.9 ZYAK	63
6.9.1 Company Profile	63
6.9.2 Product Information	64
6.9.3 Sales, Price, Revenue and Gross Margin	64
6.10 GSK	65
6.10.1 Company Profile	65
6.10.2 Product Information	66
6.10.3 Sales, Price, Revenue and Gross Margin	66
6.11 Aimei Hissen	66
6.11.1 Company Profile	66
6.11.2 Product Information	68
6.11.3 Sales, Price, Revenue and Gross Margin	68
6.12 Tianyuan Bio-pharma	69
6.12.1 Company Profile	69
6.12.2 Product Information	70
6.12.3 Sales, Price, Revenue and Gross Margin	70
6.13 Simcere Vaxtec	70
6.13.1 Company Profile	70
6.13.2 Product Information	72
6.13.3 Sales, Price, Revenue and Gross Margin	72
6.14 Tiantan Biological	73
6.14.1 Company Profile	73
6.14.2 Product Information	74
6.14.3 Sales, Price, Revenue and Gross Margin	74
7 Influenza Vaccine Manufacturing Cost Analysis	75
7.1 Influenza Vaccine Key Raw Materials Analysis	75
7.1.1 Key Raw Materials	75
7.1.2 Key Suppliers of Raw Materials	76
7.2 Proportion of Manufacturing Cost Structure	78
7.2.1 Raw Materials	78
7.2.2 Labor Cost	78
7.2.3 Other Costs Analysis	80
7.2.3 Manufacturing Expenses	82
7.3 Manufacturing Process Analysis of Influenza Vaccine	83
8 Industrial Chain, Sourcing Strategy and Downstream Buyers	84
8.1 Influenza Vaccine Industrial Chain Analysis	84
8.2 Upstream Raw Materials Sourcing	85
8.3 Downstream Buyers	85
9 Marketing Strategy Analysis, Distributors/Traders	87
9.1 Marketing Channel	87
9.1.1 Direct Marketing	87
9.1.2 Indirect Marketing	88
9.1.3 Marketing Channel Development Trend	88
9.2 Market Positioning	88
9.2.1 Pricing Strategy	88
9.2.2 Brand Strategy	90
9.2.3 Target Client	91
10 Factors Influencing	92
10.1 Price Trend of Key Industrial Raw Material	92
10.2 Imports & Exports	93
11 China Influenza Vaccine Market Size (Sales and Revenue) Forecast (2019-2025)	100
11.1 China Influenza Vaccine Sales and Revenue Forecast (2019-2025)	100
11.2 China Influenza Vaccine Sales Forecast by Type (2019-2025)	101
11.3 China Influenza Vaccine Sales Forecast by Application (2019-2025)	102
11.4 China Influenza Vaccine Sales Forecast by Regions (2019-2025)	104
12 Research Findings and Conclusion	106
13 Methodology and Data Source	107
13.1 Methodology/Research Approach	107
13.1.1 Research Programs/Design	107
13.1.2 Market Size Estimation	108
13.1.3 Market Breakdown and Data Triangulation	110
13.2 Data Source	111
13.2.1 Secondary Sources	111
13.2.2 Primary Sources	111
13.3 Disclaimer	112
13.4 Author List	113



List of Tables and Figures

Figure Product Picture of Influenza Vaccine	1
Figure China Influenza Vaccine Sales (K Doses) Comparison by Types (2013-2025)	2
Figure China Influenza Vaccine Sales Volume Market Share by Types in 2017	2
Figure Inactivated Influenza Vaccine Product Picture	3
Figure Pandemic Influenza Vaccine Product Picture	3
Figure Subunit Influenza Vaccine Product Picture	4
Table China Influenza Vaccine Sales (K Doses) Comparison by Applications (2013-2025)	4
Figure China Sales Market Share (%) of Influenza Vaccine by Applications in 2017	5
Figure For Children (6 months to 3 years) Examples	5
Figure For Adults and Children over 3 years Examples	6
Table China Influenza Vaccine Market Size (M USD) Comparison by Region (2013-2025)	6
Figure South China Influenza Vaccine Revenue (M USD) and Growth Rate (2013-2025)	7
Figure East China Influenza Vaccine Revenue (M USD) and Growth Rate (2013-2025)	8
Figure Southwest China Influenza Vaccine Revenue (M USD) and Growth Rate (2013-2025)	9
Figure Northeast China Influenza Vaccine Revenue (M USD) and Growth Rate (2013-2025)	10
Figure North China Influenza Vaccine Revenue (M USD) and Growth Rate (2013-2025)	11
Figure Central China Influenza Vaccine Revenue (M USD) and Growth Rate (2013-2025)	12
Figure Northwest China Influenza Vaccine Revenue (M USD) and Growth Rate (2013-2025)	13
Figure China Influenza Vaccine Sales (K Doses) and Growth Rate (%) (2013-2025)	14
Figure China Influenza Vaccine Revenue (M USD) and Growth Rate (2013-2025)	15
Figure GDP for Major Regions in 2016	16
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060	17
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016	17
Figure Saving Rate Total, % of GDP, 2015	18
Figure Forecast of Global Middle-Class Population, 2015 to 2030	18
Figure Fertility Rates per Woman, 1970 to 2015	19
Figure Average Years of Schooling of the Adult Population	19
Figure Household Disposable Income Gross adjusted, US dollars/capita, 2016	20
Figure Household Spending Total, Million US dollars, 2015	20
Figure Net National Income Total, US dollars/capita, 2017	21
Table China Influenza Vaccine Sales (K Doses) of Key Players/Manufacturers (2013-2018)	22
Table China Influenza Vaccine Sales Share (%) by Players/Manufacturers (2013-2018)	22
Figure 2017 China Influenza Vaccine Sales Share (%) by Players/Manufacturers	23
Figure 2018 China Influenza Vaccine Sales Share (%) by Players/Manufacturers	24
Table China Influenza Vaccine Revenue (M USD) by Players/Manufacturers (2013-2018)	24
Table China Influenza Vaccine Revenue Market Share (%) by Players/Manufacturers (2013-2018)	25
Figure 2017 China Influenza Vaccine Revenue Market Share (%) by Players/Manufacturers	26
Figure 2018 China Influenza Vaccine Revenue Market Share (%) by Players/Manufacturers	27
Table China Market Influenza Vaccine Average Price (USD/Doses) of Key Players/Manufacturers (2013-2018)	27
Figure China Market Influenza Vaccine Average Price of Key Players/Manufacturers in 2017	28
Figure 2017 China Influenza Vaccine Revenue Market Share (%) by Players/Manufacturers	29
Figure China Influenza Vaccine Market Share of Top 3 Players/Manufacturers in 2017	30
Figure China Influenza Vaccine Market Share of Top 5Players/Manufacturers in 2017	31
Table Mergers & Acquisitions, Expansion in China Market	31
Table China Players/Manufacturers Influenza Vaccine Headquarters and Established Date	34
Table China Influenza Vaccine Sales (K Doses) by Regions (2013-2018)	35
Table China Influenza Vaccine Sales Share (%) by Regions (2013-2018)	35
Figure China Influenza Vaccine Sales Share (%) by Regions (2013-2018)	36
Figure China Influenza Vaccine Sales Market Share (%) by Regions in 2017	36
Table China Influenza Vaccine Revenue (M USD) and Market Share by Regions (2013-2018)	37
Table China Influenza Vaccine Revenue Market Share (%) by Regions (2013-2018)	37
Figure China Influenza Vaccine Revenue Market Share (%) by Regions (2013-2018)	38
Figure China Influenza Vaccine Revenue Market Share (%) by Regions in 2017	38
Table China Influenza Vaccine Price (USD/Doses) by Regions (2013-2018)	39
Table China Influenza Vaccine Sales (K Doses) by Type (2013-2018)	40
Table China Influenza Vaccine Sales Share (%) by Type (2013-2018)	40
Figure China Influenza Vaccine Sales Share (%) by Type (2013-2018)	41
Figure China Influenza Vaccine Sales Market Share (%) by Type in 2017	41
Table China Influenza Vaccine Revenue (M USD) and Market Share by Type (2013-2018)	42
Table China Influenza Vaccine Revenue Market Share (%) by Type (2013-2018)	42
Figure Revenue Market Share of Influenza Vaccine by Type (2013-2018)	43
Figure Revenue Market Share of Influenza Vaccine by Type in 2017	43
Table China Influenza Vaccine Price (USD/Doses) by Types (2013-2018)	44
Figure China Influenza Vaccine Sales Growth Rate (%) by Type (2013-2018)	44
Table China Influenza Vaccine Sales (K Doses) by Applications (2013-2018)	45
Table China Influenza Vaccine Sales Market Share (%) by Applications (2013-2018)	45
Figure China Influenza Vaccine Sales Market Share (%) by Applications (2013-2018)	46
Figure China Influenza Vaccine Sales Market Share (%) by Applications in 2017	46
Table China Influenza Vaccine Sales Growth Rate (%) by Applications (2013-2018)	47
Figure China Influenza Vaccine Sales Growth Rate (%) by Applications (2013-2018)	47
Table Hualan Bio Company Profile	48
Figure Influenza Vaccine Product Picture of Hualan Bio	49
Table Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of Hualan Bio 2013-2018	49
Table SANOFI Company Profile	50
Figure Influenza Vaccine Product Picture of SANOFI	51
Table Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of SANOFI 2013-2018	51
Table CCBIO Company Profile	51
Figure Influenza Vaccine Product Picture of CCBIO	53
Table Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of CCBIO 2013-2018	53
Table Changsheng Biological Company Profile	54
Figure Influenza Vaccine Product Picture of Changsheng Biological	55
Table Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of Changsheng Biological 2013-2018	55
Table SINOVAC Company Profile	55
Figure Influenza Vaccine Product Picture of SINOVAC	56
Table Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of SINOVAC 2013-2018	57
Table SIOBP Company Profile	57
Figure Influenza Vaccine Product Picture of SIOBP	59
Table Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of SIOBP 2013-2018	59
Table Aleph Biomedical Company Profile	59
Figure Influenza Vaccine Product Picture of Aleph Biomedical	60
Table Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of Aleph Biomedical 2013-2018	61
Table Adimmune Company Profile	61
Figure Influenza Vaccine Product Picture of Adimmune	62
Table Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of Adimmune 2013-2018	62
Table ZYAK Company Profile	63
Figure Influenza Vaccine Product Picture of ZYAK	64
Table Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of ZYAK 2013-2018	64
Table GSK Company Profile	65
Figure Influenza Vaccine Product Picture of GSK	66
Table Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of GSK 2013-2018	66
Table Aimei Hissen Company Profile	66
Figure Influenza Vaccine Product Picture of Aimei Hissen	68
Table Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of Aimei Hissen 2013-2018	68
Table Tianyuan Bio-pharma Company Profile	69
Figure Influenza Vaccine Product Picture of Tianyuan Bio-pharma	70
Table Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of Tianyuan Bio-pharma 2013-2018	70
Table Simcere Vaxtec Company Profile	70
Figure Influenza Vaccine Product Picture of Simcere Vaxtec	72
Table Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of Simcere Vaxtec 2013-2018	72
Table Tiantan Biological Company Profile	73
Figure Influenza Vaccine Product Picture of Tiantan Biological	74
Table Influenza Vaccine Sales (K Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of Tiantan Biological 2013-2018	74
Table Suppliers and Pictures of Raw Material	75
Table Key Suppliers of Raw Materials	76
Table Manufacturing Cost Structure of Influenza Vaccine	78
Figure Monthly Minimum Wages in Asia 2016	78
Figure China Labor Costs 2015-2018	79
Figure Global Electricity Prices by Select Countries in 2017 (in U.S. Dollars per Kilowatt Hour)	80
Table China Cost of Electricity 2017 (PER KWH)	81
Figure Manufacturing Process Analysis of Influenza Vaccine	83
Figure Influenza Vaccine Industrial Chain Analysis	84
Table Major Buyers of Influenza Vaccine	85
Figure Influenza Vaccine Chain Circulation System	87
Figure Setting Pricing Policy	89
Figure Price Trend of Crude Oil (USD/BBL)	92
Figure Price Trend of Brent Crude Oil (USD/BBL)	92
Figure Price Trend of Natural Gas (MMBtu)	93
Figure Price Trend of Gasoline (GAL)	93
Figure China’s Import Value	94
Figure China’s Import by Category	95
Figure China’s Import Origins	96
Figure China’s Export Value	97
Figure China’s Export by Category	98
Figure China’s Export Destinations	99
China Trade Balance	99
Figure China Influenza Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2019-2025)	100
Figure China Influenza Vaccine Revenue (M USD) and Growth Rate Forecast (2019-2025)	101
Table China Influenza Vaccine Sales (K Doses) Forecast by Type (2019-2025)	101
Figure China Influenza Vaccine Sales (K Doses) Forecast by Type (2019-2025)	101
Figure China Influenza Vaccine Sales Volume Market Share Forecast by Type in 2025	102
Table China Influenza Vaccine Sales (K Doses) Forecast by Application (2019-2025)	102
Figure China Influenza Vaccine Sales Volume Market Share Forecast by Application (2019-2025)	103
Figure China Influenza Vaccine Sales Volume Market Share Forecast by Application in 2025	103
Table China Influenza Vaccine Sales (K Doses) Forecast by Regions (2019-2025)	104
Table China Influenza Vaccine Sales Volume Share Forecast by Regions (2019-2025)	104
Figure China Influenza Vaccine Sales Volume Share Forecast by Regions (2019-2025)	105
Figure China Influenza Vaccine Sales Volume Share Forecast by Regions in 2025	105
Table Research Programs/Design for This Report	107
Figure Bottom-up and Top-down Approaches for This Report	109
Figure Data Triangulation	110
Table Key Data Information from Secondary Sources	111
Table Key Data Information from Primary Sources	112

Latest News

21-Nov-2017 | Others

Price Crash in International Market Reduced Margins in Dairy Sector

The profit margins of Indian dairy companies have fallen sharply. For the past few months, skimmed milk powder (SMP) prices have fallen in the international market. Apart from this, the GST in the domestic market has doubled the tax on GST compared to the earlier rates. Due to this, dairy companies have reduced procurement prices from 10% to 22% for the last few months. Prakash Kutwal, secretar ...

21-Nov-2017 | Agriculture

Rising Implementation of Automation to Burgeon the Agricultural Robots Market

Technological progression has had a wide-ranging influence on a variety of industries such as food & beverage, packaging, agriculture, construction, and healthcare. With the constant demographic rush, the food demand is rapidly mounting by the customers. This has resulted in the gradual implementation of technological solutions to propel the agricultural output by the agricultural industry. ...

15-Nov-2017 | IT & Telecommunications

Inclusion of Cortana to Skype Will Boost the Global Artificial Intelligence Market

The US-located tech major Microsoft has declared that Cortana, its virtual assistant, will now be accessible on Skype, its video communication tool. This decision of the company is sure to boost the global artificial intelligence market. As per official blog post of Microsoft, this feature will be obtainable starting this week for both Android and iOS consumers in the U.S., but as of now there ...

15-Nov-2017 | Consumer Goods & Retailing

Increasing Demand for Carbon Black to Boost Its Market

Carbon black is a deep black-colored, fine powder that is produced by burning hydrocarbons in inadequate air. Owing to its conducting, tinting, and reinforcing properties, it is used in numerous sectors. The largest consumer of carbon black is the tire industry. It elevates the abrasion resistance and tensile strength of the automotive tires and offers strength and longevity. There has been a s ...

06-Nov-2017 | Medical Devices

Low Tolerance toward Pest Nuisance to Boost the Home Insecticide Market

Insecticides are acknowledged to be extensively utilized to deter, kill, or control insects in the agriculture and correlated field action. These insect-demolishing agents can be organic and synthetic as well in nature or a mixture of both. However, the rising demand to wipe out the presence of insect in households has resulted in a positive growth of the home insecticide market. Several insect ...